Background/Aims: This study examines whether it is harmful that subjects with an alcohol use disorder (AUD) in the general population rarely seek treatment. Methods: Baseline and 3-year follow-up data from the Netherlands Mental Health Survey and Incidence Study-2 were used. Treatment utilization covered a 4-year period. The Composite International Diagnostic Interview 3.0 assessed AUD and other psychiatric disorders. Results: Of 154 subjects with baseline 12-month DSM-5 AUD, 35.4% used only general treatment (GenTx) for mental problems or alcohol/drugs problems; 10.3% used specialized AUD treatment (AUDTx); and 54.3% used no treatment at all. Of these 3 groups, AUDTx users had the highest severity on AUD characteristics, comorbid psychopathology and mental functioning. Compared to non-treatment (NonTx), GenTx users more often had 12-month emotional disorders at follow-up, but AUD remission rates and functioning were similar. NonTx users functioned similarly at follow-up as people in the general population without lifetime AUD or other psychopathology. Conclusion: Adequate treatment seeking often occurs in the general population: the most severe AUD subjects use AUDTx, and most NonTx users have a mild AUD and a favorable course. Current findings suggest a smaller treatment gap than previously reported, but still one-quarter of the people with AUD do not seek AUDTx but could benefit from this, as they have a persistent AUD.

1.
Grant BF: Barriers to alcoholism treatment: reasons for not seeking treatment in a general population sample. J Stud Alcohol 1997;58:365-371.
2.
Edlund MJ, Booth BM, Han X: Who seeks care where? Utilization of mental health and substance use disorder treatment in two national samples of individuals with alcohol use disorders. J Stud Alcohol Drugs 2012;73:635-646.
3.
Bijl RV, de Graaf R, Hiripi E, Kessler RC, Kohn R, Offord DR, et al: The prevalence of treated and untreated mental disorders in five countries. Health Aff (Millwood) 2003;22:122-133.
4.
ten Have M, de Graaf R, van Dorsselaer S, Beekman A: Lifetime treatment contact and delay in treatment seeking after first onset of a mental disorder. Psychiatr Serv 2013;64:981-989.
5.
Wang PS, Angermeyer M, Borges G, Bruffaerts R, Tat Chiu W, de Girolamo G, et al: Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's world mental health survey initiative. World Psychiatry 2007;6:177-185.
6.
Bruffaerts R, Bonnewyn A, Demyttenaere K: Delays in seeking treatment for mental disorders in the Belgian general population. Soc Psychiatry Psychiatr Epidemiol 2007;42:937-944.
7.
Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC: Failure and delay in initial treatment contact after first onset of mental disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005;62:603-613.
8.
Ilgen MA, Price AM, Burnett-Zeigler I, Perron B, Islam K, Bohnert ASB, et al: Longitudinal predictors of addictions treatment utilization in treatment-naïve adults with alcohol use disorders. Drug Alcohol Depend 2011;113:215-221.
9.
Oleski J, Mota N, Cox BJ, Sareen J: Perceived need for care, help seeking, and perceived barriers to care for alcohol use disorders in a national sample. Psychiatr Serv 2010;61:1223-1231.
10.
Cohen E, Feinn R, Arias A, Kranzler HR: Alcohol treatment utilization: findings from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend 2007;86:214-221.
11.
Grella CE, Karno MP, Warda US, Moore AA, Niv N: Perceptions of need and help received for substance dependence in a national probability survey. Psychiatr Serv 2009;60:1068-1074.
12.
Grella CE, Stein JA: Remission from substance dependence: differences between individuals in a general population longitudinal survey who do and do not seek help. Drug Alcohol Depend 2013;133:146-153.
13.
ten Have M, Nuyen J, Beekman A, de Graaf R: Common mental disorder severity and its association with treatment contact and treatment intensity for mental health problems. Psychol Med 2013;43:2203-2213.
14.
Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J, Fleiz C, et al: Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican national comorbidity survey. Psychol Med 2005;35:1773-1783.
15.
Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R: The relationship between excessive alcohol consumption and alcohol use disorders according to DSM-IV and DSM-5. Alcohol Clin Exp Res 2014;38:249-256.
16.
Moos RH, Moos BS: Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction 2006;101:212-222.
17.
Lopez-Quintero C, Hasin DS, de los Cobos JP, Pines A, Wang S, Grant BF, et al: Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the national epidemiologic survey on alcohol and related conditions. Addiction 2011;106:657-669.
18.
Tuithof M, ten Have M, Van den Brink W, Vollebergh W, de Graaf R: Predicting persistency of DSM-5 alcohol use disorder and examining drinking patterns of recently remitted individuals: a prospective general population study. Addiction 2013;108:2091-2099.
19.
de Bruijn C, van den Brink W, de Graaf R, Vollebergh WA: The three year course of alcohol use disorders in the general population: DSM-IV, ICD-10 and the craving withdrawal model. Addiction 2006;101:385-392.
20.
Dawson DA, Goldstein RB, Grant BF: Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up. Alcohol Clin Exp Res 2007;31:2036-2045.
21.
Dawson DA, Goldstein RB, Ruan WJ, Grant BF: Correlates of recovery from alcohol dependence: a prospective study over a 3-year follow-up interval. Alcohol Clin Exp Res 2012;36:1268-1277.
22.
de Graaf R, ten Have M, van Dorsselaer S: The Netherlands mental health survey and incidence study-2 (NEMESIS-2): design and methods. Int J Methods Psychiatr Res 2010;19:125-141.
23.
de Graaf R, van Dorsselaer S, Tuithof M, ten Have M: Sociodemographic and psychiatric predictors of attrition in a prospective psychiatric epidemiological study among the general population. Result of the Netherlands mental health survey and incidence study-2. Compr Psychiatry 2013;54:1131-1139.
24.
Kessler RC, Ustun TB: The world mental health (wmh) survey initiative version of the World Health Organization (WHO) composite international diagnostic interview (CIDI). Int J Methods Psychiatr Res 2004;13:93-121.
25.
Haro JM, Arbabzadeh-Bouchez S, Brugha TS, De Girolamo G, Guyer ME, Jin R, et al: Concordance of the composite international diagnostic interview version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO world mental health surveys. Int J Methods Psychiatr Res 2006;15:167-180.
26.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Washington, American Psychiatric Association (APA), 2013.
27.
Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R: Alcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder. Drug Alcohol Depend 2014;140:85-91.
28.
Mewton L, Slade T, Teesson M: An evaluation of the proposed DSM-5 cannabis use disorder criteria using Australian national survey data. J Stud Alcohol Drugs 2013;74:614-621.
29.
Leon AC, Olfson M, Portera L, Farber L, Sheehan DV: Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 1997;27:93-105.
30.
Haynes JC, Farrell M, Singleton N, Meltzer H, Araya R, Lewis G, Wiles NJ: Alcohol consumption as a risk factor for anxiety and depression: results from the longitudinal follow-up of the national psychiatric morbidity survey. Br J Psychiatry 2005;187:544-551.
31.
British Medical Association: Alcohol Guidelines on Sensible Drinking. London, British Medical Association (BMA), 1995.
32.
Gmel G, Kuntsche E, Rehm J: Risky single-occasion drinking: bingeing is not bingeing. Addiction 2011;106:1037-1045.
33.
Li TK, Hewitt BG, Grant BF: The alcohol dependence syndrome, 30 years later: a commentary. The 2006 H. David Archibald lecture. Addiction 2007;102:1522-1530.
34.
Stewart AL, Hays RD, Ware JE Jr: The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724-735.
35.
Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
36.
Von Korff M, Crane PK, Alonso J, Vilagut G, Angermeyer MC, Bruffaerts R, et al: Modified WHODAS-II provides valid measure of global disability but filter items increased skewness. J Clin Epidemiol 2008;61:1132-1143.
37.
StataCorp: Stata Statistical Software: Release 12. College Station, StataCorp LP, 2011.
38.
Kessler RC, Üstün TB: The WHO World Mental Health Surveys. Global Perspectives on the Epidemiology of Mental Disorders. New York, Cambridge University Press, 2008.
39.
Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP: The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend 2004;74:223-234.
40.
Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, et al: Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiatry 2015;72:757-766.
41.
de Graaf R, Bijl RV, Smit F, Ravelli A, Vollebergh WA: Psychiatric and sociodemographic predictors of attrition in a longitudinal study: the Netherlands mental health survey and incidence study (NEMESIS). Am J Epidemiol 2000;152:1039-1047.
42.
Eaton WW, Anthony JC, Tepper S, Dryman A: Psychopathology and attrition in the epidemiologic catchment area surveys. Am J Epidemiol 1992;135:1051-1059.
43.
Lamers F, Hoogendoorn AW, Smit JH, van Dyck R, Zitman FG, Nolen WA, et al: Sociodemographic and psychiatric determinants of attrition in the Netherlands study of depression and anxiety (NESDA). Compr Psychiatry 2012;53:63-70.
44.
Rehm J, Allamani A, Della Vedova R, Elekes Z, Jakubczyk A, Landsmane I, et al: General practitioners recognizing alcohol dependence: a large cross-sectional study in 6 European countries. Ann Fam Med 2015;13:28-32.
45.
Merkx MJ, Schippers GM, Koeter MW, Vuijk PJ, Poch M, Kronemeijer H, et al: Predictive validity of treatment allocation guidelines on drinking outcome in alcohol-dependent patients. Addict Behav 2013;38:1691-1698.
46.
Fortney J, Mukherjee S, Curran G, Fortney S, Han X, Booth BM: Factors associated with perceived stigma for alcohol use and treatment among at-risk drinkers. J Behav Health Serv Res 2004;31:418-429.
47.
Dawson DA, Grant BF, Stinson FS, Chou PS: Estimating the effect of help-seeking on achieving recovery from alcohol dependence. Addiction 2006;101:824-834.
48.
Angus C, Latimer N, Preston L, Li J, Purshouse R: What are the implications for policy makers? A systematic review of the cost-effectiveness of screening and brief interventions for alcohol misuse in primary care. Front Psychiatry 2014;5:114.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.